Gap 27, connexin43 mimetic peptide, is a gap junction inhibitor.
CAT No: R1375
CAS No:198284-64-9
Synonyms/Alias:GAP 27;198284-64-9;GAP 27 acetate salt;DTXSID80432769;Gap27;MFCD11045577;Connexin mimetic peptide;Connexin43 mimetic peptide;Gap 27?;H-Ser-Arg-Pro-Thr-Glu-Lys-Thr-Ile-Phe-Ile-Ile-OH;DTXCID50383597;SXRAPDIXXYFGJG-MDAHIHQXSA-N;AKOS024456622;DA-63699;FG110171;TS-10350;G13727;H-Ser-Arg-Pro-Thr-Glu-Lys-Thr-Ile-Phe-Ile-Ile-OH; H-SRPTEKTIFII-OH;
1. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
3. Cationic cell-penetrating peptides are potent furin inhibitors
5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.